DK1294876T3 - EV-VEGF-nukleinsyrer og -polypeptider samt fremgangsmåder til deres benyttelse - Google Patents
EV-VEGF-nukleinsyrer og -polypeptider samt fremgangsmåder til deres benyttelseInfo
- Publication number
- DK1294876T3 DK1294876T3 DK01946701T DK01946701T DK1294876T3 DK 1294876 T3 DK1294876 T3 DK 1294876T3 DK 01946701 T DK01946701 T DK 01946701T DK 01946701 T DK01946701 T DK 01946701T DK 1294876 T3 DK1294876 T3 DK 1294876T3
- Authority
- DK
- Denmark
- Prior art keywords
- polypeptides
- methods
- present
- vegf
- well
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A61K38/1866—Vascular endothelial growth factor [VEGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/515—Angiogenesic factors; Angiogenin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Vascular Medicine (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21363700P | 2000-06-23 | 2000-06-23 | |
US23097800P | 2000-09-07 | 2000-09-07 | |
PCT/US2000/032678 WO2001040466A2 (en) | 1999-12-01 | 2000-12-01 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
PCT/US2001/020116 WO2002000711A2 (en) | 2000-06-23 | 2001-06-22 | Ev-vegf nucleic acids and polypeptides and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1294876T3 true DK1294876T3 (da) | 2009-06-02 |
Family
ID=26908256
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01946701T DK1294876T3 (da) | 2000-06-23 | 2001-06-22 | EV-VEGF-nukleinsyrer og -polypeptider samt fremgangsmåder til deres benyttelse |
Country Status (14)
Country | Link |
---|---|
US (4) | US20020172678A1 (da) |
EP (2) | EP1294876B1 (da) |
JP (1) | JP5081361B2 (da) |
KR (1) | KR100871735B1 (da) |
CN (2) | CN101269214B (da) |
AT (1) | ATE424458T1 (da) |
AU (3) | AU6871401A (da) |
CA (1) | CA2412612C (da) |
DE (1) | DE60137847D1 (da) |
DK (1) | DK1294876T3 (da) |
ES (1) | ES2323569T3 (da) |
HK (2) | HK1059452A1 (da) |
MX (1) | MXPA03000150A (da) |
WO (1) | WO2002000711A2 (da) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030032023A1 (en) * | 1997-06-16 | 2003-02-13 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US20020172678A1 (en) * | 2000-06-23 | 2002-11-21 | Napoleone Ferrara | EG-VEGF nucleic acids and polypeptides and methods of use |
US7264801B2 (en) * | 1998-08-11 | 2007-09-04 | Genentech, Inc. | EG-VEGF nucleic acids and polypeptides and method of use |
US6485938B1 (en) * | 1999-11-16 | 2002-11-26 | Zymogenetics, Inc. | Nucleic acid molecules that encodes human Zven1 |
WO2002036625A2 (en) | 2000-11-03 | 2002-05-10 | The Regents Of The University Of California | Prokineticin polypeptides, related compositions and methods |
US20050271663A1 (en) * | 2001-06-28 | 2005-12-08 | Domantis Limited | Compositions and methods for treating inflammatory disorders |
ATE477280T1 (de) * | 2001-06-28 | 2010-08-15 | Domantis Ltd | Doppelspezifischer ligand und dessen verwendung |
KR101008734B1 (ko) | 2001-08-29 | 2011-01-14 | 제넨테크, 인크. | 유사분열촉진 활성을 가진 Bv8 핵산 및 폴리펩티드 |
EP1487856B1 (en) * | 2002-03-04 | 2010-07-28 | Imclone LLC | Human antibodies specific to kdr and uses thereof |
US7598048B2 (en) | 2002-04-15 | 2009-10-06 | The Regents Of The University Of California | Screening methods for identifying agents that modulate output of a circadian pacemaker |
DE10229379A1 (de) * | 2002-06-26 | 2004-01-29 | Schering Ag | EG-VEGF Rezeptor Antagonisten |
US7696320B2 (en) | 2004-08-24 | 2010-04-13 | Domantis Limited | Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor |
EP2135879A3 (en) * | 2002-06-28 | 2010-06-23 | Domantis Limited | Ligand |
US9321832B2 (en) * | 2002-06-28 | 2016-04-26 | Domantis Limited | Ligand |
JP2006514683A (ja) * | 2002-10-07 | 2006-05-11 | ザイモジェネティクス,インコーポレイティド | ヒトzvenアンタゴニストの使用 |
EP1578801A2 (en) * | 2002-12-27 | 2005-09-28 | Domantis Limited | Dual specific single domain antibodies specific for a ligand and for the receptor of the ligand |
EP1589033A4 (en) * | 2003-01-22 | 2006-04-12 | Takeda Pharmaceutical | ANTIBODY AND ITS USE |
CA2515288A1 (en) * | 2003-03-12 | 2004-09-23 | Genentech, Inc. | Compositions with hematopoietic and immune activity |
GB0320238D0 (en) | 2003-08-29 | 2003-10-01 | Medical Res Council | Treatment of disease |
US20080219985A1 (en) * | 2005-09-13 | 2008-09-11 | Thompson Penny J | Prok2 antagonists and methods of use |
BRPI0619225A2 (pt) * | 2005-12-01 | 2017-11-07 | Domantis Ltd | monômero de anticorpo de domínio, ligando, ácidos nucleicos isolado e recombinante, vetor, célula hospedeira, método para produzir um monômero de dab de ligando, composição farmacêutica, dispositivo de liberação de medicamento, uso de um monômero de anticorpo de domínio, e, método para tratar uma doença inflamatória, artrite ou doença respiratória |
KR100781753B1 (ko) * | 2006-05-24 | 2007-12-04 | 연세대학교 산학협력단 | Dkk2를 포함하는 혈관신생을 촉진시키는 방법 |
WO2008014547A1 (en) * | 2006-07-31 | 2008-02-07 | David Le Couteur | Cells genetically modified to express markers of fenestration and uses thereof |
JP2010528647A (ja) * | 2007-06-06 | 2010-08-26 | ドマンティス リミテッド | ポリペプチド、抗体可変ドメインおよびアンタゴニスト |
CN105102478A (zh) * | 2013-01-30 | 2015-11-25 | 弗拉芒区生物技术研究所 | 用于筛选和药物发现目的的新型嵌合多肽 |
WO2014201283A1 (en) * | 2013-06-12 | 2014-12-18 | The Regents Of The University Of California | Methods for protecting ovarian function |
JP2015127307A (ja) * | 2013-12-27 | 2015-07-09 | 国立大学法人福井大学 | 抗prok1抗体による大腸癌の治療 |
JP6320040B2 (ja) * | 2013-12-27 | 2018-05-09 | 国立大学法人福井大学 | 抗prok1抗体及び抗vegf抗体併用による大腸癌の治療 |
US12061205B2 (en) | 2016-12-12 | 2024-08-13 | Morphic Medical, Inc. | Methods for assessing treatment with a gastrointestinal implant |
RU2662944C1 (ru) * | 2017-02-17 | 2018-07-31 | Общество с ограниченной ответственностью "Группа развития "АПЕКС" | Средство для лечения состояний человеческого организма, связанных с уменьшением уровня экспрессии гена prok 1 и/или уменьшением количества белка прокинетицина 1 на основе генно-терапевтических субстанций с геном prok 1, способ получения и использования |
US11793889B2 (en) | 2018-09-24 | 2023-10-24 | Kinase Pharma Inc. | Methods for selective kinase inhibition by endogenously produced antagonists of one or more kinases |
CN111621466B (zh) * | 2020-06-09 | 2020-12-29 | 首都医科大学附属北京朝阳医院 | 一种肺动脉组织单细胞悬液的制备方法及应用 |
Family Cites Families (109)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
US4657760A (en) | 1979-03-20 | 1987-04-14 | Ortho Pharmaceutical Corporation | Methods and compositions using monoclonal antibody to human T cells |
JPS6023084B2 (ja) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
ZA811368B (en) | 1980-03-24 | 1982-04-28 | Genentech Inc | Bacterial polypedtide expression employing tryptophan promoter-operator |
US4469863A (en) | 1980-11-12 | 1984-09-04 | Ts O Paul O P | Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof |
US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
NZ201705A (en) | 1981-08-31 | 1986-03-14 | Genentech Inc | Recombinant dna method for production of hepatitis b surface antigen in yeast |
US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
US4943529A (en) | 1982-05-19 | 1990-07-24 | Gist-Brocades Nv | Kluyveromyces as a host strain |
US4870009A (en) | 1982-11-22 | 1989-09-26 | The Salk Institute For Biological Studies | Method of obtaining gene product through the generation of transgenic animals |
US4713339A (en) | 1983-01-19 | 1987-12-15 | Genentech, Inc. | Polycistronic expression vector construction |
AU2353384A (en) | 1983-01-19 | 1984-07-26 | Genentech Inc. | Amplification in eukaryotic host cells |
NZ207394A (en) | 1983-03-08 | 1987-03-06 | Commw Serum Lab Commission | Detecting or determining sequence of amino acids |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
DD266710A3 (de) | 1983-06-06 | 1989-04-12 | Ve Forschungszentrum Biotechnologie | Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase |
US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
AU3145184A (en) | 1983-08-16 | 1985-02-21 | Zymogenetics Inc. | High expression of foreign genes in schizosaccharomyces pombe |
US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
US4736866B1 (en) | 1984-06-22 | 1988-04-12 | Transgenic non-human mammals | |
US4879231A (en) | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
US5235033A (en) | 1985-03-15 | 1993-08-10 | Anti-Gene Development Group | Alpha-morpholino ribonucleoside derivatives and polymers thereof |
US5034506A (en) | 1985-03-15 | 1991-07-23 | Anti-Gene Development Group | Uncharged morpholino-based polymers having achiral intersubunit linkages |
EP0206448B1 (en) | 1985-06-19 | 1990-11-14 | Ajinomoto Co., Inc. | Hemoglobin combined with a poly(alkylene oxide) |
US5206344A (en) | 1985-06-26 | 1993-04-27 | Cetus Oncology Corporation | Interleukin-2 muteins and polymer conjugation thereof |
US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
WO1987005330A1 (en) | 1986-03-07 | 1987-09-11 | Michel Louis Eugene Bergh | Method for enhancing glycoprotein stability |
GB8610600D0 (en) | 1986-04-30 | 1986-06-04 | Novo Industri As | Transformation of trichoderma |
US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
US4946778A (en) * | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
US4946783A (en) | 1987-01-30 | 1990-08-07 | President And Fellows Of Harvard College | Periplasmic protease mutants of Escherichia coli |
US5010182A (en) | 1987-07-28 | 1991-04-23 | Chiron Corporation | DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides |
IL87737A (en) | 1987-09-11 | 1993-08-18 | Genentech Inc | Method for culturing polypeptide factor dependent vertebrate recombinant cells |
DE3850542T2 (de) | 1987-09-23 | 1994-11-24 | Bristol Myers Squibb Co | Antikörper-Heterokonjugate zur Töting von HIV-infizierten Zellen. |
GB8724885D0 (en) | 1987-10-23 | 1987-11-25 | Binns M M | Fowlpox virus promotors |
DE3889546T2 (de) | 1987-12-21 | 1994-09-08 | Univ Toledo | Transformation von keimenden pflanzensamen mit hilfe von agrobacterium. |
US5216141A (en) | 1988-06-06 | 1993-06-01 | Benner Steven A | Oligonucleotide analogs containing sulfur linkages |
AU4005289A (en) | 1988-08-25 | 1990-03-01 | Smithkline Beecham Corporation | Recombinant saccharomyces |
GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
US5240848A (en) | 1988-11-21 | 1993-08-31 | Monsanto Company | Dna sequences encoding human vascular permeability factor having 189 amino acids |
US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
US5225538A (en) | 1989-02-23 | 1993-07-06 | Genentech, Inc. | Lymphocyte homing receptor/immunoglobulin fusion proteins |
US5009772A (en) | 1989-02-27 | 1991-04-23 | Kerr-Mcgee Corporation | Solvent extraction process |
ES2055907T3 (es) | 1989-03-07 | 1994-09-01 | Genentech Inc | Conjugados covalentes de lipidos y oligonucleotidos. |
FR2646437B1 (fr) | 1989-04-28 | 1991-08-30 | Transgene Sa | Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant |
ES2038579T3 (es) | 1989-04-28 | 1997-02-16 | Rhein Biotech Proz & Prod Gmbh | Celulas de levadura del genero schwanniomyces. |
WO1990013641A1 (en) | 1989-05-10 | 1990-11-15 | Sloan-Kettering Institute For Cancer Research | Stably transformed eucaryotic cells comprising a foreign transcribable dna under the control of a pol iii promoter |
US5332671A (en) | 1989-05-12 | 1994-07-26 | Genetech, Inc. | Production of vascular endothelial cell growth factor and DNA encoding same |
EP0402226A1 (en) | 1989-06-06 | 1990-12-12 | Institut National De La Recherche Agronomique | Transformation vectors for yeast yarrowia |
DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
WO1991000360A1 (en) | 1989-06-29 | 1991-01-10 | Medarex, Inc. | Bispecific reagents for aids therapy |
FR2649120B1 (fr) | 1989-06-30 | 1994-01-28 | Cayla | Nouvelle souche et ses mutants de champignons filamenteux, procede de production de proteines recombinantes a l'aide de ladite souche et souches et proteines obtenues selon ce procede |
WO1991004753A1 (en) | 1989-10-02 | 1991-04-18 | Cetus Corporation | Conjugates of antisense oligonucleotides and therapeutic uses thereof |
US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
US5225212A (en) | 1989-10-20 | 1993-07-06 | Liposome Technology, Inc. | Microreservoir liposome composition and method |
EP0498843B1 (en) | 1989-10-24 | 1996-06-12 | Gilead Sciences, Inc. | Oligonucleotide analogs with novel linkages |
US5602240A (en) | 1990-07-27 | 1997-02-11 | Ciba Geigy Ag. | Backbone modified oligonucleotide analogs |
US5386023A (en) | 1990-07-27 | 1995-01-31 | Isis Pharmaceuticals | Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling |
US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
ATE158021T1 (de) | 1990-08-29 | 1997-09-15 | Genpharm Int | Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper |
US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
US5206161A (en) | 1991-02-01 | 1993-04-27 | Genentech, Inc. | Human plasma carboxypeptidase B |
US5185450A (en) | 1991-02-19 | 1993-02-09 | University Of South Florida | Tetrazolium compounds for cell viability assays |
CA2102511A1 (en) | 1991-05-14 | 1992-11-15 | Paul J. Higgins | Heteroconjugate antibodies for treatment of hiv infection |
WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
EP1136556B1 (en) | 1991-11-25 | 2005-06-08 | Enzon, Inc. | Method of producing multivalent antigen-binding proteins |
US5644048A (en) | 1992-01-10 | 1997-07-01 | Isis Pharmaceuticals, Inc. | Process for preparing phosphorothioate oligonucleotides |
PT752248E (pt) | 1992-11-13 | 2001-01-31 | Idec Pharma Corp | Aplicacao terapeutica de anticorpos quimericos e marcados radioactivamente contra antigenios de diferenciacao restrita de linfocitos b humanos para o tratamento do linfoma de celulas b |
DK0674506T3 (da) | 1992-12-02 | 2001-01-08 | Alkermes Inc | Væksthormonholdige mikrosfærer med styret frigivelse |
JP2879303B2 (ja) | 1993-01-14 | 1999-04-05 | 佑 本庶 | cDNAライブラリーの作製方法、および新規なポリペプチドとそれをコードするDNA |
US5531697A (en) | 1994-04-15 | 1996-07-02 | Sims Deltec, Inc. | Systems and methods for cassette identification for drug pumps |
US5637684A (en) | 1994-02-23 | 1997-06-10 | Isis Pharmaceuticals, Inc. | Phosphoramidate and phosphorothioamidate oligomeric compounds |
WO2000053753A2 (en) * | 1999-03-08 | 2000-09-14 | Genentech, Inc. | Promotion or inhibition of angiogenesis and cardiovascularization |
EP0779806B2 (en) | 1994-09-09 | 2008-04-16 | Takeda Pharmaceutical Company Limited | Sustained release preparation containing metal salt of a peptide |
US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
DK0831787T3 (da) | 1995-06-07 | 2001-12-17 | Alkermes Inc | Sammensætning til vedvarende frigivelse af humant væksthormon |
ZA965368B (en) | 1995-07-14 | 1997-01-14 | Novo Nordisk As | A pharmaceutical formulation |
US5707829A (en) | 1995-08-11 | 1998-01-13 | Genetics Institute, Inc. | DNA sequences and secreted proteins encoded thereby |
US6458939B1 (en) | 1996-03-15 | 2002-10-01 | Millennium Pharmaceuticals, Inc. | Compositions and methods for the diagnosis, prevention, and treatment of neoplastic cell growth and proliferation |
US5858682A (en) * | 1996-08-02 | 1999-01-12 | Pharmingen | E2A/pbx1 fusion protein specific monoclonal antibodies |
US6013780A (en) | 1996-09-06 | 2000-01-11 | Technion Research & Development Co. Ltd. | VEGF145 expression vectors |
US5824504A (en) | 1996-09-26 | 1998-10-20 | Elshourbagy; Nabil A. | Human 7-transmembrane receptor and DNA |
WO2000075327A1 (en) * | 1999-06-02 | 2000-12-14 | Genentech, Inc. | Methods and compositions for inhibiting neoplastic cell growth |
WO1999063088A2 (en) | 1998-06-02 | 1999-12-09 | Genentech, Inc. | Membrane-bound proteins and nucleic acids encoding the same |
ATE244579T1 (de) * | 1997-01-22 | 2003-07-15 | Univ Texas | Verfahren und zusammensetzungen des gewebefaktors zur koagulation und behandlung von tumoren |
WO1998039448A2 (en) | 1997-03-07 | 1998-09-11 | Human Genome Sciences, Inc. | 186 human secreted proteins |
WO1998042741A2 (en) | 1997-03-25 | 1998-10-01 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
US20030032023A1 (en) | 1997-06-16 | 2003-02-13 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
AU8555198A (en) * | 1997-08-01 | 1999-02-22 | Genset | 5' ests for secreted proteins expressed in prostate |
DE19811194A1 (de) | 1998-03-10 | 1999-09-16 | Metagen Gesellschaft Fuer Genomforschung Mbh | Menschliche Nukleinsäuresequenzen aus Prostatagewebe |
DE19817557A1 (de) | 1998-04-09 | 1999-10-21 | Metagen Gesellschaft Fuer Genomforschung Mbh | Menschliche Nukleinsäuresequenzen aus Ovartumorgewebe |
JPH11332571A (ja) | 1998-05-29 | 1999-12-07 | Taisho Pharmaceut Co Ltd | 新規遺伝子とそれにコードされる蛋白質 |
CA2337904A1 (en) | 1998-08-03 | 2000-02-17 | Novartis Ag | Novel genes in control of hematopoiesis |
US20020172678A1 (en) * | 2000-06-23 | 2002-11-21 | Napoleone Ferrara | EG-VEGF nucleic acids and polypeptides and methods of use |
US7264801B2 (en) * | 1998-08-11 | 2007-09-04 | Genentech, Inc. | EG-VEGF nucleic acids and polypeptides and method of use |
CA2296792A1 (en) | 1999-02-26 | 2000-08-26 | Genset S.A. | Expressed sequence tags and encoded human proteins |
EP1173456A4 (en) * | 1999-03-01 | 2005-10-12 | Millennium Pharm Inc | SECRETED PROTEINS AND NUCLEIC ACIDS ENCODING THEM |
CA2373231A1 (en) * | 1999-05-19 | 2000-11-23 | Incyte Genomics, Inc. | Extracellular signaling molecules |
JP2004522402A (ja) * | 1999-06-02 | 2004-07-29 | ジェネンテック・インコーポレーテッド | 同一のものをコードする分泌及び膜貫通ポリペプチドと核酸 |
US6485938B1 (en) * | 1999-11-16 | 2002-11-26 | Zymogenetics, Inc. | Nucleic acid molecules that encodes human Zven1 |
WO2001036465A2 (en) | 1999-11-16 | 2001-05-25 | Zymogenetics, Inc. | Human zven proteins |
CA2491433A1 (en) * | 1999-12-01 | 2001-06-07 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
WO2001057190A2 (en) | 2000-02-03 | 2001-08-09 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
CA2515288A1 (en) * | 2003-03-12 | 2004-09-23 | Genentech, Inc. | Compositions with hematopoietic and immune activity |
-
2001
- 2001-06-20 US US09/886,242 patent/US20020172678A1/en not_active Abandoned
- 2001-06-22 AT AT01946701T patent/ATE424458T1/de not_active IP Right Cessation
- 2001-06-22 CA CA2412612A patent/CA2412612C/en not_active Expired - Fee Related
- 2001-06-22 EP EP01946701A patent/EP1294876B1/en not_active Expired - Lifetime
- 2001-06-22 KR KR1020027017547A patent/KR100871735B1/ko not_active IP Right Cessation
- 2001-06-22 AU AU6871401A patent/AU6871401A/xx active Pending
- 2001-06-22 CN CN2008100991719A patent/CN101269214B/zh not_active Expired - Fee Related
- 2001-06-22 ES ES01946701T patent/ES2323569T3/es not_active Expired - Lifetime
- 2001-06-22 MX MXPA03000150A patent/MXPA03000150A/es active IP Right Grant
- 2001-06-22 AU AU2001268714A patent/AU2001268714B2/en not_active Ceased
- 2001-06-22 DE DE60137847T patent/DE60137847D1/de not_active Expired - Lifetime
- 2001-06-22 EP EP09002242.7A patent/EP2075334B1/en not_active Expired - Lifetime
- 2001-06-22 WO PCT/US2001/020116 patent/WO2002000711A2/en active Search and Examination
- 2001-06-22 JP JP2002505833A patent/JP5081361B2/ja not_active Expired - Fee Related
- 2001-06-22 CN CN018146007A patent/CN1449445B/zh not_active Expired - Fee Related
- 2001-06-22 DK DK01946701T patent/DK1294876T3/da active
-
2003
- 2003-10-22 US US10/692,299 patent/US7446168B2/en not_active Expired - Fee Related
-
2004
- 2004-03-31 HK HK04102330.1A patent/HK1059452A1/xx not_active IP Right Cessation
-
2006
- 2006-09-29 US US11/537,382 patent/US7727536B2/en not_active Expired - Fee Related
- 2006-12-20 AU AU2006252241A patent/AU2006252241B2/en not_active Ceased
-
2009
- 2009-12-23 HK HK09112118.3A patent/HK1132298A1/xx not_active IP Right Cessation
-
2010
- 2010-03-16 US US12/724,964 patent/US8557238B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2323569T3 (es) | 2009-07-21 |
CA2412612C (en) | 2013-04-30 |
WO2002000711A3 (en) | 2002-06-20 |
JP5081361B2 (ja) | 2012-11-28 |
EP1294876A2 (en) | 2003-03-26 |
CN101269214B (zh) | 2013-09-04 |
EP1294876B1 (en) | 2009-03-04 |
AU6871401A (en) | 2002-01-08 |
WO2002000711A2 (en) | 2002-01-03 |
ATE424458T1 (de) | 2009-03-15 |
AU2001268714B2 (en) | 2006-09-21 |
KR100871735B1 (ko) | 2008-12-03 |
US8557238B2 (en) | 2013-10-15 |
US7727536B2 (en) | 2010-06-01 |
CN1449445A (zh) | 2003-10-15 |
EP2075334A1 (en) | 2009-07-01 |
CN1449445B (zh) | 2012-07-18 |
DE60137847D1 (de) | 2009-04-16 |
JP2004511432A (ja) | 2004-04-15 |
AU2006252241B2 (en) | 2010-03-04 |
US20020172678A1 (en) | 2002-11-21 |
CN101269214A (zh) | 2008-09-24 |
KR20030011104A (ko) | 2003-02-06 |
US20100254999A1 (en) | 2010-10-07 |
EP2075334B1 (en) | 2013-11-20 |
AU2006252241A1 (en) | 2007-01-25 |
MXPA03000150A (es) | 2003-09-22 |
HK1132298A1 (en) | 2010-02-19 |
HK1059452A1 (en) | 2004-07-02 |
US20070122412A1 (en) | 2007-05-31 |
US20050064522A1 (en) | 2005-03-24 |
US7446168B2 (en) | 2008-11-04 |
CA2412612A1 (en) | 2002-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1294876T3 (da) | EV-VEGF-nukleinsyrer og -polypeptider samt fremgangsmåder til deres benyttelse | |
ATE541930T1 (de) | Il-17-homologe polypeptide und ihre therapeutische verwendung | |
ATE447583T1 (de) | Polypeptide und dafür kodierende nukleinsäure | |
CY1106885T1 (el) | Θεραπευτικες χρησεις il-17-ομολογων πολυπεπτιδιων | |
PT1169442E (pt) | Polipeptidos segregados e transmembranares e acidos nucleicos que os codificam | |
DE69939227D1 (de) | Menschliches A33-Antigen-ähnliches Protein und dafür kodierende Nukleinsäure | |
ATE380864T1 (de) | Menschliches prostasin-ähnliches protein und dafür kodierende nukleinsäure | |
DE69926415D1 (de) | Sekretiertes Polypeptide und dafür kodierende Nukleinsäuren | |
DK1300417T3 (da) | Secerneret og transmembrant polypeptid og nucleinsyre kodende derfor | |
DE69827532D1 (de) | Polypeptide und dafür kodierende Nukleinsäure | |
ATE404585T1 (de) | Menschliches synaptogyrin-ähnliches protein und dafür kodierende nukleinsäure | |
ATE405590T1 (de) | Menschliches hcar-ähnliches protein und dafür kodierende nukleinsäure | |
DE60038986D1 (de) | Ausgeschiedene und Transmembranpolypeptide und dafür kodierende Nukleinsäure | |
DK1191101T3 (da) | PRO241 polypeptider og nucleinsyre kodende herfor | |
ATE363537T1 (de) | Ausgeschiedene und transmembranpolypeptide und dafür kodierende nukleinsäure | |
ATE447026T1 (de) | Ausgeschiedene und transmembrane polypeptide und dafür kodierende nukleinsäure | |
ATE447614T1 (de) | Menschliches suppressor von fused |